Breaking News, Collaborations & Alliances

Quotient Sciences Supports Crinetics Pharma with Pediatric Development, Clinical Testing Program

Quotient to use translational pharmaceutics platform to provide formulation development, clinical manufacturing, and taste assessment studies.

Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug development and manufacturing accelerator, entered into a partnership to support Crinetics’ CRN04894 pediatric program. The alliance will utilize Quotient Sciences’ Translational Pharmaceutics platform to provide integrated formulation development, clinical manufacturing, and taste assessment studies to accelerate Crinetics’ development timeline. Crinetics ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters